PAVmed Inc. — Director's Dealing 2016

May 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-04-28

Reporting Person: Aklog Lishan (Director, Chairman and CEO, 10% Owner)
Reporting Person: HCFP/Capital Partners III LLC (10% Owner)
Reporting Person: Pavilion Venture Partners LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-28	Common Stock	A	12000	—	Acquired	2520532	Indirect
2016-04-28	Common Stock	A	87020	—	Acquired	87020	Indirect
2016-04-28	Common Stock	A	125000	—	Acquired	125000	Indirect
2016-04-28	Common Stock	A	20000	—	Acquired	20000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-28	Warrants	$5.00	A	12000	Acquired	2022-01-29	Common Stock (12000)	Indirect
2016-04-28	Warrants	$5.00	A	87020	Acquired	2022-01-29	Common Stock (87020)	Indirect
2016-04-28	Warrants	$5.00	A	125000	Acquired	2022-01-29	Common Stock (125000)	Indirect
2016-04-28	Warrants	$5.00	A	20000	Acquired	2022-01-29	Common Stock (20000)	Indirect
2016-04-28	Employee Stock Option (Right to Buy)	$5.00	A	278726	Acquired	2026-04-28	Common Stock (278726)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5713879	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$5.00	2022-01-29	Common Stock (5713879)	5713879	Indirect

Footnotes

F1: Dr. Aklog is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F2: The reporting person purchased units from the issuer, each unit consisting of one share of the issuer's common stock and one warrant, at a price of $5.00 per unit. Each warrant entitles the holder to purchase one share of the issuer's common stock at an exercise price of $5.00 per share, subject to adjustment.

F3: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F4: Dr. Aklog is a controlling shareholder of HCFP Inc., and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F5: Dr. Aklog is a member and a co-manager of the entity that acts as sole manager of HCFP/Capital Partners IIIB LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F6: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the shares held by this entity. Dr. Aklog disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F7: The option vests as to 3/36 of the shares on July 28, 2016 and in 33 equal monthly installments thereafter.